Cargando…

CALN1 hypomethylation as a biomarker for high-risk bladder cancer

BACKGROUND: DNA methylation in cancer is considered a diagnostic and predictive biomarker. We investigated the usefulness of the methylation status of CALN1 as a biomarker for bladder cancer using methylation-sensitive restriction enzyme (MSRE)-quantitative polymerase chain reaction (qPCR). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi, Kimiaki, Naruse, Azumi, Akita, Kazutoshi, Muramatsu-Maekawa, Yuka, Kawase, Kota, Koie, Takuya, Horie, Masanobu, Kikuchi, Arizumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647952/ https://www.ncbi.nlm.nih.gov/pubmed/36352401 http://dx.doi.org/10.1186/s12894-022-01136-y

Ejemplares similares

Prognostic Value of the Controlling Nutritional Status (CONUT) Score in Patients at Dialysis Initiation
por: Takagi, Kimiaki, et al.
Publicado: (2022)

Gallbladder metastasis from renal cell carcinoma: A case report and literature review
por: Takagi, Kimiaki, et al.
Publicado: (2019)

Retroperitoneal lipogranuloma mimicking recurrence of renal cell carcinoma after laparoscopic partial nephrectomy
por: Takagi, Kimiaki, et al.
Publicado: (2019)

Liver and Pancreas Transplantation: Report on the Marjorie Budd Lecture by Professor R. Y. Calne
Publicado: (1985)

Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer
por: Takagi, Kimiaki, et al.
Publicado: (2022)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab
por: Iinuma, Koji, et al.
Publicado: (2021)

Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2021)

Endoscopic combined intrarenal surgery for renal allograft lithiasis using “sheath-connection technique”: A case report
por: Sugino, Fumiya, et al.
Publicado: (2023)

Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer
por: Kawase, Makoto, et al.
Publicado: (2022)

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2023)

Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies
por: Tomioka, Masayuki, et al.
Publicado: (2021)

Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study
por: Yamada, Toyohiro, et al.
Publicado: (2022)

The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma
por: Tomioka-Inagawa, Risa, et al.
Publicado: (2022)

Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer
por: Tomioka, Masayuki, et al.
Publicado: (2021)

ALK Gene Translocation in Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report
por: Takagi, Kimiaki, et al.
Publicado: (2015)

Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer
por: Maesaka, Fumisato, et al.
Publicado: (2022)

Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2022)

Diabetes Mellitus as a Predictive Factor for Urinary Tract Infection for Patients Treated with Kidney Transplantation
por: Ozawa, Kaori, et al.
Publicado: (2022)

Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma
por: Nishida, Naoshi, et al.
Publicado: (2013)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Solitary Fibrous Tumor of the Prostate: A Case Report and Literature Review
por: Takeuchi, Yasumichi, et al.
Publicado: (2021)

Hyperglycemic memory in the rat bladder detrusor is associated with a persistent hypomethylated state
por: Wang, Yi, et al.
Publicado: (2020)

The Impact of Postoperative Renal Function Recovery after Laparoscopic and Robot-Assisted Partial Nephrectomy in Patients with Renal Cell Carcinoma
por: Kawase, Kota, et al.
Publicado: (2022)

Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center
por: Takeuchi, Shinichi, et al.
Publicado: (2022)

Efficacy and Safety of the “Trisection Method” Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan
por: Nakane, Keita, et al.
Publicado: (2022)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Kubota, Yuka, et al.
Publicado: (2019)

Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer
por: Takeuchi, Shinichi, et al.
Publicado: (2023)

Potential Mechanisms of Aberrant DNA Hypomethylation on the X Chromosome in Uterine Leiomyomas
por: SATO, Shun, et al.
Publicado: (2013)

Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker
por: Sung, Hye Youn, et al.
Publicado: (2018)

SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer
por: Ansar, Muhamad, et al.
Publicado: (2020)

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
por: Li, Xuanxuan, et al.
Publicado: (2023)

Role of Huge Geometric Circular Structures in the Reproduction of a Marine Pufferfish
por: Kawase, Hiroshi, et al.
Publicado: (2013)

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging
por: Kato, Daiki, et al.
Publicado: (2021)

Clinical Predictors of Grade Group Upgrading for Radical Prostatectomy Specimens Compared to Those of Preoperative Needle Biopsy Specimens
por: Tomioka, Masayuki, et al.
Publicado: (2022)

Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer
por: Wolff, Erika M., et al.
Publicado: (2010)

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
por: Nagata, Masayoshi, et al.
Publicado: (2016)

Long Interspersed Nuclear Element-1 Hypomethylation and Oxidative Stress: Correlation and Bladder Cancer Diagnostic Potential
por: Patchsung, Maturada, et al.
Publicado: (2012)

A Case of Muscle-Invasive Bladder Cancer With Pelvic Lymph Node Involvement Treated With Pembrolizumab and Subsequent Radical Cystectomy and Maintained No Evidence of Disease After Surgery
por: Takeuchi, Shinichi, et al.
Publicado: (2021)

A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical Prostatectomy
por: Kawase, Makoto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ics7pcjhvttfk4r5564gndu4av